592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV unrelated HNSCC
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Journal for ImmunoTherapy of Cancer - 11(2023), Suppl 1 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jeffrey Schlom [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
|---|
| doi: |
10.1136/jitc-2023-SITC2023.0592 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ098380818 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ098380818 | ||
| 003 | DE-627 | ||
| 005 | 20240413222335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jitc-2023-SITC2023.0592 |2 doi | |
| 035 | |a (DE-627)DOAJ098380818 | ||
| 035 | |a (DE-599)DOAJa3fab307059b40dc927bf48861453429 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC254-282 | |
| 100 | 0 | |a Jeffrey Schlom |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV unrelated HNSCC |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 653 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
| 700 | 0 | |a James L Gulley |e verfasserin |4 aut | |
| 700 | 0 | |a Jennifer Marte |e verfasserin |4 aut | |
| 700 | 0 | |a Elizabeth Lamping |e verfasserin |4 aut | |
| 700 | 0 | |a Lisa Cordes |e verfasserin |4 aut | |
| 700 | 0 | |a Seth M Steinberg |e verfasserin |4 aut | |
| 700 | 0 | |a Charalampos Floudas |e verfasserin |4 aut | |
| 700 | 0 | |a Jason M Redman |e verfasserin |4 aut | |
| 700 | 0 | |a Clint Allen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal for ImmunoTherapy of Cancer |d BMJ Publishing Group, 2013 |g 11(2023), Suppl 1 |w (DE-627)DOAJ000014281 |x 20511426 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g number:Suppl 1 |
| 856 | 4 | 0 | |u https://doi.org/10.1136/jitc-2023-SITC2023.0592 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a3fab307059b40dc927bf48861453429 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2051-1426 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2023 |e Suppl 1 | ||